Closing the Gap: Why Timely Pediatric ADHD Assessment Is a Digital Health Imperative

The Scale of the Problem

Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent neurodevelopmental conditions affecting children in the United States today. According to the CDC’s 2022 National Survey of Children’s Health, an estimated 7 million U.S. children aged 3–17 years have ever received an ADHD diagnosis—approximately 11.4% of that population. That figure rose by roughly one million children compared to 2016. Despite this scale, nearly 30% of children with current ADHD received no medication or behavioural treatment in 2022, and access to formal diagnostic evaluation remains deeply uneven across geographies, income levels, and racial and ethnic groups.

The question is not whether ADHD in children is a public health priority. It clearly is. The question is why the pathway from a child showing ADHD signs to receiving a formal ADHD evaluation for children remains so fraught with delay, disparity, and inefficiency, and how evidence-based innovations are beginning to change that.

The Access Gap Is Real and Well-Documented

The barriers that families face when seeking ADHD assessment for a child are not anecdotal. A 2024 systematic review published in the Journal of Attention Disorders analysed 30 studies covering barriers and enablers of ADHD service access for children and adolescents, identifying five core thematic challenges: awareness of ADHD, stigma, parental choice and partnerships, educational system gaps, and, critically, referral pathways, wait times, and logistical obstacles.

Those logistical barriers span multiple dimensions of a family’s life. Among the most commonly cited in the research:

• Extended wait times for specialist appointments, which can stretch from weeks to months in many regions
• Geographic distance from child psychiatry services, disproportionately affecting rural and low-income communities
• Cost and insurance coverage limitations that limit access to comprehensive psychological evaluations
• Parental inability to take time off work for multiple in-person clinic visits
• Stigma and limited ADHD awareness, particularly in underserved and non-English-speaking households
• Shortage of trained diagnosticians, especially child psychiatrists and pediatric neuropsychologists

Children with undiagnosed ADHD are more likely to experience academic failure, social difficulties, and co-occurring anxiety or behavioural problems, all of which compound over time. The same CDC data shows that nearly 78% of children with current ADHD have at least one co-occurring condition, with almost half experiencing anxiety and nearly half experiencing behaviour or conduct problems.

Telehealth as a Structural Solution, Not Just a Convenience

The COVID-19 pandemic forced a rapid, large-scale experiment in telehealth-based pediatric mental health care. For ADHD services specifically, that experiment produced meaningful evidence. Telehealth approaches, primarily videoconferencing and telephone-based care, showed positive outcomes across multiple domains for children with ADHD: clinical outcomes, access to care, patient and family experience, caregiver experience, and clinician experience.

Importantly, the European ADHD Guidelines Group (EAGG) issued formal recommendations on remote ADHD assessment following the pandemic, concluding that telehealth approaches are viable for initial assessment and ongoing monitoring of ADHD in children and adolescents. The guidelines noted that families often valued the practical advantages: reduced travel time, no loss of parental earnings, and, for hyperactive and impulsive children, the removal of the stress of long journeys to clinic appointments.

Telehealth does not merely replicate in-person care through a screen. When designed well, it restructures the pathway entirely by:

• Reducing the number of visits required,
• Enabling school-based input without pulling educators into clinic settings, and
• Expanding the catchment area of specialist services far beyond what physical infrastructure allows.

Digital Assessment Tools: Moving Beyond Subjective Reporting

Beyond care delivery, the assessment process itself is being transformed by digital tools. Traditional ADHD evaluation relies heavily on clinician judgment, parent and teacher rating scales, and behavioural observation—all of which are valid but time-intensive and subject to reporting variability. Digital assessment technologies spanning wearables, eye-tracking, computerised continuous performance tests, machine learning models, and gamified screening tools hold significant potential for scalable, high-quality diagnostic support.

Digital approaches could also be designed to screen large numbers of children and increase access to evaluations, particularly in community settings where specialist psychologists are not present.

These tools are not replacements for clinical judgment. But they represent a meaningful expansion of what is possible when assessment is viewed as a system design problem rather than simply a clinical one. 

Disparities That Innovation Must Confront Directly

Any serious discussion of digital health innovation in pediatric ADHD must grapple with equity. There are persistent disparities in both diagnosis and treatment across racial, ethnic, socioeconomic, and linguistic lines. Children in non-English-speaking households were significantly more likely to go untreated.

Black and Hispanic children were underdiagnosed relative to population prevalence. Children without health insurance were less than half as likely to have been diagnosed as those with public coverage.

Telehealth has shown promise in narrowing some of these gaps, but has not closed them automatically. Innovators and health system leaders should approach digital ADHD care with explicit equity objectives, including:

• Multilingual patient intake, rating scales, and psychoeducation materials that reflect the linguistic diversity of families seeking care
• Asynchronous digital assessment options that reduce the dependency on real-time clinic availability and rigid scheduling
• School-integrated models that allow teacher input to be gathered digitally without requiring attendance at specialist appointments
• Pathways that explicitly address the needs of children with co-occurring conditions, such as autism spectrum disorder, anxiety, or learning disabilities, who are often the most difficult to refer and the longest to wait
• Payer and reimbursement models that support telehealth-delivered evaluation and follow-up care, particularly for Medicaid-enrolled populations where ADHD rates are higher, and access is most constrained

What a Streamlined Assessment Pathway Looks Like

Healthcare systems experimenting with redesigned pediatric ADHD pathways have demonstrated that wait times can be cut substantially without sacrificing clinical rigour. Implementing a “fast track” triage and assessment model for complex ADHD has been found to cut evaluation wait times in half while confirming ADHD diagnoses (along with at least one co-occurring condition) in the majority of children assessed. Critically, for 64% of children, the fast-track assessment changed the diagnostic picture, resulting in revised treatment planning.

The key design principles emerging from this and similar work include: pre-visit digital data collection from parents and teachers to reduce the information-gathering burden of the first appointment; structured, standardized intake processes that allow clinicians to focus on clinical judgment rather than administrative work; and a single point of access into the assessment pathway, rather than multiple referral loops that delay entry into care.

These are, in essence, workflow design and technology problems as much as clinical ones. The EHR, the patient portal, the digital intake form, and the telehealth platform are the architecture through which families either reach a timely diagnosis or fall through the cracks.

ADHD Prevalence Trends Demand a Systems-Level Response

There are stable and elevated diagnosis rates across children and adolescents. The steady prevalence, rather than a brief post-pandemic spike, underscores that demand on pediatric ADHD assessment services is structural, not situational.

Health system leaders cannot plan around this as though capacity will naturally expand to meet demand. Without deliberate investment in scalable, technology-enabled assessment pathways, wait times will continue to grow, disparities will persist, and children will continue to enter classrooms and early adolescence without the support they need.

The good news is that the evidence base for what works is growing rapidly. Telehealth-delivered ADHD treatment and monitoring have demonstrated clinical effectiveness in randomised controlled trials. Digital assessment tools are moving from research settings into clinical practice. 

The Role of Specialised Providers in a Digital-First Landscape

As digital health infrastructure scales, the role of specialised neurodevelopmental assessment providers becomes more important, not less. Technology can broaden reach and reduce friction, but it cannot replace clinical expertise in differentiating ADHD from anxiety, processing differences, autism, or the cognitive effects of chronic stress and adverse childhood experiences. 

For health systems building or procuring digital ADHD care platforms, integration with specialist assessment services, including providers of neurodevelopmental evaluation across ADHD, autism, and related conditions, is essential. It ensures that children receive not just a faster pathway, but an accurate and clinically meaningful one.

The Opportunity for Healthcare Innovators

Pediatric ADHD sits at the intersection of several of the most pressing challenges in digital health: care access inequity, workforce shortages in pediatric psychiatry, the need for scalable yet clinically rigorous assessment tools, and the demand for patient and family experience that is not built around the convenience of health systems but around the realities of family life.

For innovators, system leaders, EHR developers, and telehealth platform designers, the call to action is clear:

• The tools exist
• The evidence is building, and
• The need is undeniable

Closing the gap in pediatric ADHD assessment is not just a clinical goal. It is a health system design challenge, and one that the digital health community is well-positioned to solve.

About the Author

Dr. Darren O’Reilly is the neurodivergent founder and CEO of AuDHD Psychiatry – a UK-led neurodevelopmental assessment service. The clinic provides private online ADHD, Autism, and combined (AuDHD) assessments for adults and children across the UK. Its multidisciplinary team of psychologists, consultant psychiatrists, prescribers, and ADHD coaches offers compassionate, evidence-based diagnosis, medication, and ongoing support, helping clients gain clarity, confidence, and faster access to care.

https://www.linkedin.com/in/dr-darren-o-reilly-adhd-coach-psychologist/